AbbVie Inc. (ABBV) Stock Grade

About AbbVie Inc.'s fundamentals

AbbVie is a large-cap pharmaceutical company with a $470.7 billion market capitalization that generated 8.6% year-over-year revenue growth, indicating solid top-line expansion within the drug manufacturing sector. The company maintains a net profit margin of 6.9%, which is relatively modest for its size and reflects the capital-intensive nature of pharmaceutical operations. With a P/E ratio of 95.9, investors are pricing in substantial future earnings expectations, while the company offers a 3.0% dividend yield that may appeal to income-focused investors.